Logo Image
News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All Videos10 Things That Got Me Through TreatmentCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVCalled to CareEducated Patient Sound BitesExercise of the WeekFrom All AnglesOn Demand: WebinarsShortsText a SurvivorThe Breast Cancer BriefingThe Cancer Search Bar
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryCURE CookbookClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gallbladder Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Advanced Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement

Timothy Burns

Advertisement

Articles by Timothy Burns

Out of Several Recent Drug Approvals in NSCLC, Tabrecta Most 'Practice Changing' of All, According to Expert

ByRyan McDonald,Timothy Burns
July 13th 2020

“One FDA approval that we were quite excited about (is Tabrecta). And I've actually already put some patients on it; it's a very good drug,” Dr. Timothy Burns said in a recent interview.

Advertisement

Latest Updated Articles

  • Out of Several Recent Drug Approvals in NSCLC, Tabrecta Most 'Practice Changing' of All, According to Expert
    Out of Several Recent Drug Approvals in NSCLC, Tabrecta Most 'Practice Changing' of All, According to Expert

    July 13th 2020



Advertisement
Advertisement

Trending on CURE

1

5 Years of Prostate Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients

2

FDA Grants Final Approval to OMCAZIO, a New Capsule Formulation of Cabozantinib

3

5 Years of Lung Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients

4

What Your Friend with Cancer REALLY Needs

5

Getting on My Ovarian Cancer Awareness Soap Box Again Because I Love My Daughter

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.